Dexmedetomidine for Peri-operative Sedation and Analgesia in Children Undergoing Bilateral Myringotomy With Tube Placement (BMT) (DexBMT)

NCT00654329 Phase 4 COMPLETED Results posted

A randomized controlled clinical trial to examine effects of intranasal dexmedetomidine, an α2-adrenorecptor agonist, on pain control and agitation in children undergoing BMT.

Details

Lead sponsor	Children's National Research Institute
Phase	Phase 4
Status	COMPLETED
Enrolment	101
Start date	2005-08
Completion	2008-12

Conditions

• Otitis

Interventions

• Saline
• Fentanyl
• Dexmedetomidine
• Dexmedetomidine

Primary outcomes

• Incidence of Pain — up to 24 hours
  Pain greater than a zero reported in the Post Anesthesia Care Unit (PACU)

Countries

United States